CoChat
Cited by 186

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Inhibin at 90: From Discovery to Clinical Application, a Historical Review

Open access
Makanji, Yogeshwar, Zhu, Jie, Mishra, Rama, Holmquist, Chris, Wong, Winifred P. S., Schwartz, Neena B., Mayo, Kelly E., Woodruff, Teresa K. · 2014 · Endocrine Reviews

Abstract

When it was initially discovered in 1923, inhibin was characterized as a hypophysiotropic hormone that acts on pituitary cells to regulate pituitary hormone secretion. Ninety years later, what we know about inhibin stretches far beyond its well-established capacity to inhibit activin signaling and suppress pituitary FSH production. Inhibin is one of the major reproductive hormones involved in the regulation of folliculogenesis and steroidogenesis. Although the physiological role of inhibin as an activin antagonist in other organ systems is not as well defined as it is in the pituitary-gonadal axis, inhibin also modulates biological processes in other organs through paracrine, autocrine, and/or endocrine mechanisms. Inhibin and components of its signaling pathway are expressed in many organs. Diagnostically, inhibin is used for prenatal screening of Down syndrome as part of the quadruple test and as a biochemical marker in the assessment of ovarian reserve. In this review, we provide a comprehensive summary of our current understanding of the biological role of inhibin, its relationship with activin, its signaling mechanisms, and its potential value as a diagnostic marker for reproductive function and pregnancy-associated conditions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/er.2014-1003

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 537

  1. McCullagh, 1932, Dual endocrine activity of the testes, Science, 76, 19, 10.1126/science.76.1957.19 · DOI · Paper page
  2. Mottram, 1923, On the general effects of exposure to radium on metabolism and tumour growth in the rat and the special effects on testis and pituitary, J Exp Physiol, 13, 209, 10.1113/expphysiol.1923.sp000291 · doi:10.1113/expphysiol.1923.sp000291
  3. Schwartz, 1977, Evidence for ovarian “inhibin”: suppression of the secondary rise in serum follicle stimulating hormone levels in proestrous rats by injection of porcine follicular fluid, Proc Natl Acad Sci USA, 74, 5721, 10.1073/pnas.74.12.5721 · DOI · Paper page
  4. Keogh, 1976, Selective suppression of FSH by testicular extracts, Endocrinology, 98, 997, 10.1210/endo-98-4-997 · doi:10.1210/endo-98-4-997
  5. Robertson, 1985, Isolation of inhibin from bovine follicular fluid, Biochem Biophys Res Commun, 126, 220, 10.1016/0006-291X(85)90594-7 · DOI · Paper page
  6. Rivier, 1985, Purification and partial characterization of inhibin from porcine follicular fluid, Biochem Biophys Res Commun, 133, 120, 10.1016/0006-291X(85)91849-2 · DOI · Paper page
  7. Ling, 1985, Isolation and partial characterization of a Mr 32,000 protein with inhibin activity from porcine follicular fluid, Proc Natl Acad Sci USA, 82, 7217, 10.1073/pnas.82.21.7217 · DOI · Paper page
  8. Miyamoto, 1985, Isolation of porcine follicular fluid inhibin of 32K daltons, Biochem Biophys Res Commun, 129, 396, 10.1016/0006-291X(85)90164-0 · DOI · Paper page
  9. Esch, 1987, Complementary deoxyribonucleic acid (cDNA) cloning and DNA sequence analysis of rat ovarian inhibins, Mol Endocrinol, 1, 388, 10.1210/mend-1-5-388 · DOI · Paper page
  10. Forage, 1986, Cloning and sequence analysis of cDNA species coding for the two subunits of inhibin from bovine follicular fluid, Proc Natl Acad Sci USA, 83, 3091, 10.1073/pnas.83.10.3091 · DOI · Paper page
  11. Mason, 1985, Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-β, Nature, 318, 659, 10.1038/318659a0 · DOI · Paper page
  12. Mayo, 1986, Inhibin A-subunit cDNAs from porcine ovary and human placenta, Proc Natl Acad Sci USA, 83, 5849, 10.1073/pnas.83.16.5849 · DOI · Paper page
  13. Woodruff, 1987, Rat inhibin: molecular cloning of α- and β-subunit complementary deoxyribonucleic acids and expression in the ovary, Mol Endocrinol, 1, 561, 10.1210/mend-1-8-561 · DOI · Paper page
  14. Burger, 2001, The inhibins and ovarian cancer, Mol Cell Endocrinol, 180, 145, 10.1016/S0303-7207(01)00519-6 · doi:10.1016/s0303-7207(01)00519-6
  15. de Kretser, 2001, Inhibins, activins and follistatin: actions on the testis, Mol Cell Endocrinol, 180, 87, 10.1016/S0303-7207(01)00502-0 · DOI
  16. Hillier, 1993, Inhibin, activin, and follistatin. Potential roles in ovarian physiology, Ann N Y Acad Sci, 687, 29, 10.1111/j.1749-6632.1993.tb43850.x · DOI
  17. Jaffe, 1993, Activins and inhibins: gonadal peptides during prenatal development and adult life, Ann N Y Acad Sci, 687, 1, 10.1111/j.1749-6632.1993.tb43846.x · doi:10.1111/j.1749-6632.1993.tb43846.x
  18. Lambert-Messerlian, 2004, Inhibins and activins in human fetal abnormalities, Mol Cell Endocrinol, 225, 101, 10.1016/j.mce.2004.02.019 · DOI
  19. Makanji, 2011, Feedback regulation by inhibins A and B of the pituitary secretion of follicle-stimulating hormone, Vitam Horm, 85, 299, 10.1016/B978-0-12-385961-7.00014-7 · DOI
  20. Mather, 1992, Paracrine regulation of reproductive function by inhibin and activin, Proc Soc Exp Biol Med, 201, 1, 10.3181/00379727-201-43473 · DOI · Paper page
  21. Matzuk, 1996, Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development, Recent Prog Horm Res, 51, 123
  22. Mayo, 1994, Inhibin and activin molecular aspects of regulation and function, Trends Endocrinol Metab, 5, 407, 10.1016/1043-2760(95)92523-L · DOI
  23. McNeilly, 2012, Diagnostic applications for inhibin and activins, Mol Cell Endocrinol, 359, 121, 10.1016/j.mce.2011.06.017 · doi:10.1016/j.mce.2011.06.017
  24. Petraglia, 1991, Inhibin subunits in human placenta: localization and messenger ribonucleic acid levels during pregnancy, Am J Obstet Gynecol, 165, 750, 10.1016/0002-9378(91)90323-J · doi:10.1016/0002-9378(91)90323-j
  25. Qu, 1995, Inhibin and activin production in human placenta, Endocr Rev, 16, 485, 10.1210/edrv-16-4-485 · DOI
  26. Robertson, 2012, Inhibins and activins in blood: predictors of female reproductive health?, Mol Cell Endocrinol, 359, 78, 10.1016/j.mce.2011.05.016 · doi:10.1016/j.mce.2011.05.016
  27. De Jong, 1976, Evidence for inhibin-like activity in bovine follicular fluid, Nature, 263, 71, 10.1038/263071a0 · DOI · Paper page
  28. Setchell, 1974, Inhibin-like activity in rete testis fluid, J Endocrinol, 62, 675, 10.1677/joe.0.0620675 · DOI
  29. Woodruff, 1990, Inhibin and activin locally regulate rat ovarian folliculogenesis, Endocrinology, 127, 3196, 10.1210/endo-127-6-3196 · DOI · Paper page
  30. Hsueh, 1987, Heterodimers and homodimers of inhibin subunits have different paracrine action in the modulation of luteinizing hormone-stimulated androgen biosynthesis, Proc Natl Acad Sci USA, 84, 5082, 10.1073/pnas.84.14.5082 · DOI · Paper page
  31. Baly, 1993, Development of a specific and sensitive two-site enzyme-linked immunosorbent assay for measurement of inhibin-A in serum, Endocrinology, 132, 2099, 10.1210/endo.132.5.8477659 · doi:10.1210/endo.132.5.8477659
  32. Betteridge, 1991, A two-site enzyme-linked immunosorbent assay for inhibin, Biol Reprod, 45, 748, 10.1095/biolreprod45.5.748 · doi:10.1095/biolreprod45.5.748
  33. Wong, 1993, Monoclonal antibody based ELISAs for measurement of activins in biological fluids, J Immunol Methods, 165, 1, 10.1016/0022-1759(93)90100-L · DOI
  34. Woodruff, 1993, Quantitative two-site enzyme-linked immunosorbent assays for inhibin A, activin A and activin B, Hum Reprod, 8, 133, 10.1093/humrep/8.suppl_2.133 · doi:10.1093/humrep/8.suppl_2.133
  35. Chari, 1976, A convenient and rapid bioassay for inhibin, Horm Res, 7, 129, 10.1159/000178720 · doi:10.1159/000178720
  36. Nandini, 1976, A model system for studying inhibin, Endocrinology, 98, 1460, 10.1210/endo-98-6-1460 · doi:10.1210/endo-98-6-1460
  37. Ramasharma, 1979, A rapid bioassay for measuring inhibin activity, Biol Reprod, 20, 831, 10.1095/biolreprod20.4.831 · doi:10.1095/biolreprod20.4.831
  38. de Jong, 1979, Bioassay of inhibin-like activity using pituitary cells in vitro, J Endocrinol, 80, 91, 10.1677/joe.0.0800091 · doi:10.1677/joe.0.0800091
  39. Eddie, 1979, A bioassay for inhibin using pituitary cell cultures, J Endocrinol, 81, 49, 10.1677/joe.0.0810049 · DOI
  40. Hudson, 1979, Bioassays for inhibin: a critical review, J Reprod Fertil Suppl, 26, 17
  41. Scott, 1980, A simple and rapid in vitro bioassay for inhibin, Endocrinology, 107, 1536, 10.1210/endo-107-5-1536 · DOI · Paper page
  42. Leversha, 1987, Isolation of inhibin from ovine follicular fluid, J Endocrinol, 113, 213, 10.1677/joe.0.1130213 · DOI
  43. Good, 1995, Isolation of nine different biologically and immunologically active molecular variants of bovine follicular inhibin, Biol Reprod, 53, 1478, 10.1095/biolreprod53.6.1478 · doi:10.1095/biolreprod53.6.1478
  44. Ireland, 1994, Alterations in amounts of different forms of inhibin during follicular atresia, Biol Reprod, 50, 1265, 10.1095/biolreprod50.6.1265 · doi:10.1095/biolreprod50.6.1265
  45. Knight, 1989, Evidence that the bovine ovary secretes large amounts of monomeric inhibin α subunit and its isolation from bovine follicular fluid, J Mol Endocrinol, 2, 189, 10.1677/jme.0.0020189 · doi:10.1677/jme.0.0020189
  46. Miyamoto, 1986, Demonstration of high molecular weight forms of inhibin in bovine follicular fluid (bFF) by using monoclonal antibodies to bFF 32K inhibin, Biochem Biophys Res Commun, 136, 1103, 10.1016/0006-291X(86)90447-X · doi:10.1016/0006-291x(86)90447-x
  47. Sugino, 1992, Purification and characterization of high molecular weight forms of inhibin from bovine follicular fluid, Endocrinology, 130, 789
  48. Moore, 1994, Initial characterization of equine inhibin, Biol Reprod, 51, 63, 10.1095/biolreprod51.1.63 · doi:10.1095/biolreprod51.1.63
  49. Grootenhuis, 1990, Inhibin in immature rat Sertoli cell conditioned medium: a 32 kDa α β-B dimer, Mol Cell Endocrinol, 70, 109, 10.1016/0303-7207(90)90064-F · DOI
  50. Hancock, 1992, Inhibin and inhibin α-chain precursors are produced by immature rat Sertoli cells in culture, Biol Reprod, 46, 155, 10.1095/biolreprod46.1.155 · DOI
  51. Noguchi, 1997, Ontogeny of inhibin secretion in the rat testis: secretion of inhibin-related proteins from fetal Leydig cells and of bioactive inhibin from Sertoli cells, J Endocrinol, 155, 27, 10.1677/joe.0.1550027 · DOI
  52. Majumdar, 1997, A study of the relative roles of follicle-stimulating hormone and luteinizing hormone in the regulation of testicular inhibin secretion in the rhesus monkey (Macaca mulatta), Endocrinology, 138, 1363, 10.1210/endo.138.4.5058 · doi:10.1210/endo.138.4.5058
  53. Winters, 1999, Partial characterization of circulating inhibin-B and pro-αC during development in the male rhesus monkey, Endocrinology, 140, 5497, 10.1210/endo.140.12.7167 · DOI
  54. Robertson, 1996, Biological and immunological characterization of inhibin forms in human plasma, J Clin Endocrinol Metab, 81, 669
  55. Robertson, 1997, The biological and immunological characterization of inhibin A and B forms in human follicular fluid and plasma, J Clin Endocrinol Metab, 82, 889
  56. Findlay, 1989, Immunisation against the amino-terminal peptide (α N) of the α 43 subunit of inhibin impairs fertility in sheep, Endocrinology, 124, 3122, 10.1210/endo-124-6-3122 · doi:10.1210/endo-124-6-3122
  57. Robertson, 1986, Isolation of a 31 kDa form of inhibin from bovine follicular fluid, Mol Cell Endocrinol, 44, 271, 10.1016/0303-7207(86)90133-4 · DOI
  58. McLachlan, 1986, The radioimmunoassay of bovine and human follicular fluid and serum inhibin, Mol Cell Endocrinol, 46, 175, 10.1016/0303-7207(86)90096-1 · doi:10.1016/0303-7207(86)90096-1
  59. McLachlan, 1987, Circulating immunoreactive inhibin levels during the normal human menstrual cycle, J Clin Endocrinol Metab, 65, 954, 10.1210/jcem-65-5-954 · DOI · Paper page
  60. Groome, 1990, Monoclonal and polyclonal antibodies reactive with the 1–32 amino terminal sequence of the α subunit of human 32K inhibin, Hybridoma, 9, 31, 10.1089/hyb.1990.9.31 · DOI
  61. Groome, 1994, Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay, Clin Endocrinol (Oxf), 40, 717, 10.1111/j.1365-2265.1994.tb02504.x · DOI · Paper page
  62. Groome, 1996, Measurement of dimeric inhibin B throughout the human menstrual cycle, J Clin Endocrinol Metab, 81, 1401
  63. Groome, 1991, Preparation of monoclonal antibodies to the β A subunit of ovarian inhibin using a synthetic peptide immunogen, Hybridoma, 10, 309, 10.1089/hyb.1991.10.309 · DOI
  64. Knight, 1996, Development and application of a two-site enzyme immunoassay for the determination of ‘total’ activin-A concentrations in serum and follicular fluid, J Endocrinol, 148, 267, 10.1677/joe.0.1480267 · DOI · Paper page
  65. Knight, 1994, Measurement of dimeric inhibin using a modified two-site immunoradiometric assay specific for oxidized (Met O) inhibin, J Endocrinol, 141, 417, 10.1677/joe.0.1410417 · doi:10.1677/joe.0.1410417
  66. Ludlow, 2008, Development of a new antibody to the human inhibin/activin βB subunit and its application to improved inhibin B ELISAs, J Immunol Methods, 329, 102, 10.1016/j.jim.2007.09.013 · doi:10.1016/j.jim.2007.09.013
  67. Robertson, 2001, Development of an inhibin α subunit ELISA with broad specificity, Mol Cell Endocrinol, 180, 79, 10.1016/S0303-7207(01)00518-4 · doi:10.1016/s0303-7207(01)00518-4
  68. Robertson, 2002, Characterization of inhibin forms and their measurement by an inhibin α-subunit ELISA in serum from postmenopausal women with ovarian cancer, J Clin Endocrinol Metab, 87, 816
  69. Ling, 1986, Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibin, Nature, 321, 779, 10.1038/321779a0 · DOI · Paper page
  70. Vale, 1986, Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid, Nature, 321, 776, 10.1038/321776a0 · DOI · Paper page
  71. Ling, 1986, A homodimer of the β-subunits of inhibin A stimulates the secretion of pituitary follicle stimulating hormone, Biochem Biophys Res Commun, 138, 1129, 10.1016/S0006-291X(86)80400-4 · DOI · Paper page
  72. Mason, 1989, Activin B: precursor sequences, genomic structure and in vitro activities, Mol Endocrinol, 3, 1352, 10.1210/mend-3-9-1352 · DOI
  73. H tten, 1995, Cloning of a new member of the TGF-β family: a putative new activin β C chain, Biochem Biophys Res Commun, 206, 608, 10.1006/bbrc.1995.1086 · DOI · Paper page
  74. Lau, 2000, Activin βC and βE genes are not essential for mouse liver growth, differentiation, and regeneration, Mol Cell Biol, 20, 6127, 10.1128/MCB.20.16.6127-6137.2000 · DOI
  75. Gold, 2009, Activin C antagonizes activin A in vitro and overexpression leads to pathologies in vivo, Am J Pathol, 174, 184, 10.2353/ajpath.2009.080296 · DOI
  76. Makanji, 2009, Inhibin B is a more potent suppressor of rat follicle-stimulating hormone release than inhibin A in vitro and in vivo, Endocrinology, 150, 4784, 10.1210/en.2008-1783 · DOI
  77. Woodruff, 1993, Pharmacokinetic profile of recombinant human (rh) inhibin A and activin A in the immature rat. I. Serum profile of rh-inhibin A and rh-activin A in the immature female rat, Endocrinology, 132, 715, 10.1210/endo.132.2.8425490 · DOI
  78. Woodruff, 1993, Pharmacokinetic profile of recombinant human (rh) inhibin A and activin A in the immature rat. II. Tissue distribution of [125I]rh-inhibin A and [125I]rh-activin A in immature female and male rats, Endocrinology, 132, 725, 10.1210/endo.132.2.8425491 · DOI
  79. Mason, 1996, Characterization and determination of the biological activities of noncleavable high molecular weight forms of inhibin A and activin A, Mol Endocrinol, 10, 1055
  80. Woodruff, 1990, Regulation of inhibin synthesis in the rat ovary, Annu Rev Physiol, 52, 807, 10.1146/annurev.ph.52.030190.004111 · DOI
  81. Esch, 1987, Structural characterization of follistatin: a novel follicle-stimulating hormone release-inhibiting polypeptide from the gonad, Mol Endocrinol, 1, 849, 10.1210/mend-1-11-849 · DOI · Paper page
  82. Mason, 1986, Structure of two human ovarian inhibins, Biochem Biophys Res Commun, 135, 957, 10.1016/0006-291X(86)91021-1 · DOI · Paper page
  83. Gray, 1990, Requirement for activin A and transforming growth factor–β 1 pro-regions in homodimer assembly, Science, 247, 1328, 10.1126/science.2315700 · DOI · Paper page
  84. Antenos, 2008, An activin/furin regulatory loop modulates the processing and secretion of inhibin α- and βB-subunit dimers in pituitary gonadotrope cells, J Biol Chem, 283, 33059, 10.1074/jbc.M804190200 · DOI
  85. Antenos, 2011, Role of PCSK5 expression in mouse ovarian follicle development: identification of the inhibin α- and β-subunits as candidate substrates, PLoS One, 6, e17348, 10.1371/journal.pone.0017348 · DOI
  86. Hauburger, 2009, The pro-form of BMP-2 interferes with BMP-2 signalling by competing with BMP-2 for IA receptor binding, FEBS J, 276, 6386, 10.1111/j.1742-4658.2009.07361.x · DOI
  87. Jasuja, 2007, Bone morphogenetic protein 1 prodomain specifically binds and regulates signaling by bone morphogenetic proteins 2 and 4, J Biol Chem, 282, 9053, 10.1074/jbc.M610929200 · DOI
  88. Gregory, 2005, The prodomain of BMP-7 targets the BMP-7 complex to the extracellular matrix, J Biol Chem, 280, 27970, 10.1074/jbc.M504270200 · DOI · Paper page
  89. Thies, 2001, GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding, Growth Factors, 18, 251, 10.3109/08977190109029114 · DOI · Paper page
  90. Makanji, 2007, Inhibin A and B in vitro bioactivities are modified by their degree of glycosylation and their affinities to betaglycan, Endocrinology, 148, 2309, 10.1210/en.2006-1612 · DOI
  91. Antenos, 2007, N-linked oligosaccharides direct the differential assembly and secretion of inhibin α- and βA-subunit dimers, Mol Endocrinol, 21, 1670, 10.1210/me.2007-0050 · DOI
  92. Walton, 2009, A common biosynthetic pathway governs the dimerization and secretion of inhibin and related transforming growth factor β (TGFβ) ligands, J Biol Chem, 284, 9311, 10.1074/jbc.M808763200 · DOI
  93. Barton, 1989, Mapping of genes for inhibin subunits α, β A, and β B on human and mouse chromosomes and studies of jsd mice, Genomics, 5, 91, 10.1016/0888-7543(89)90091-8 · doi:10.1016/0888-7543(89)90091-8
  94. Stewart, 1986, Human inhibin genes. Genomic characterisation and sequencing, FEBS Lett, 206, 329, 10.1016/0014-5793(86)81006-7 · doi:10.1016/0014-5793(86)81006-7
  95. Debieve, 2002, Control of the human inhibin α chain promoter in cytotrophoblast cells differentiating into syncytium, Mol Hum Reprod, 8, 262, 10.1093/molehr/8.3.262 · doi:10.1093/molehr/8.3.262
  96. Su, 1992, Characterization of mouse inhibin α gene and its promoter, Biochem Biophys Res Commun, 186, 293, 10.1016/S0006-291X(05)80806-X · doi:10.1016/s0006-291x(05)80806-x
  97. Walton, 2011, The synthesis and secretion of inhibins, Vitam Horm, 85, 149, 10.1016/B978-0-12-385961-7.00008-1 · DOI
  98. Vidal, 1992, Identification and mapping of six microdissected genomic DNA probes to the proximal region of mouse chromosome 1, Genomics, 14, 32, 10.1016/S0888-7543(05)80279-4 · DOI
  99. Justice, 1990, A molecular genetic linkage map of mouse chromosome 13 anchored by the beige (bg) and satin (sa) loci, Genomics, 6, 341, 10.1016/0888-7543(90)90575-F · DOI
  100. Tanimoto, 1996, Human activin βA gene. Identification of novel 5′ exon, functional promoter, and enhancers, J Biol Chem, 271, 32760, 10.1074/jbc.271.51.32760 · DOI
  101. Tanimoto, 1991, Structure and sequence analysis of the human activin β A subunit gene, DNA Seq, 2, 103, 10.3109/10425179109039678 · DOI
  102. Erämaa, 1992, Developmental and cyclic adenosine 3′,5′monophosphate-dependent regulation of inhibin subunit messenger ribonucleic acids in human fetal testes, J Clin Endocrinol Metab, 75, 806
  103. Dykema, 1994, Two messenger ribonucleic acids encoding the common β B-chain of inhibin and activin have distinct 5′-initiation sites and are differentially regulated in rat granulosa cells, Endocrinology, 135, 702, 10.1210/endo.135.2.8033818 · doi:10.1210/endo.135.2.8033818
  104. Feng, 1989, Analysis of the 5′-flanking regions of rat inhibin α- and β-B-subunit genes suggests two different regulatory mechanisms, Mol Endocrinol, 3, 1914, 10.1210/mend-3-12-1914 · DOI
  105. Robert, 2006, LRH-1/NR5A2 cooperates with GATA factors to regulate inhibin α-subunit promoter activity, Mol Cell Endocrinol, 257–258, 65, 10.1016/j.mce.2006.06.011 · DOI
  106. Tremblay, 2001, GATA factors differentially activate multiple gonadal promoters through conserved GATA regulatory elements, Endocrinology, 142, 977, 10.1210/endo.142.3.7995 · doi:10.1210/endo.142.3.7995 · Paper page
  107. Bicsak, 1986, Hormonal regulation of granulosa cell inhibin biosynthesis, Endocrinology, 119, 2711, 10.1210/endo-119-6-2711 · DOI · Paper page
  108. Tsonis, 1987, Production of inhibin bioactivity by human granulosa-lutein cells: stimulation by LH and testosterone in vitro, J Endocrinol, 112, R11, 10.1677/joe.0.112R011 · DOI
  109. Conti, 2002, Specificity of the cyclic adenosine 3′,5′-monophosphate signal in granulosa cell function, Biol Reprod, 67, 1653, 10.1095/biolreprod.102.004952 · DOI · Paper page
  110. Richards, 2001, New signaling pathways for hormones and cyclic adenosine 3′,5′-monophosphate action in endocrine cells, Mol Endocrinol, 15, 209
  111. Ito, 2000, Synergistic activation of the inhibin α-promoter by steroidogenic factor-1 and cyclic adenosine 3′,5′-monophosphate, Mol Endocrinol, 14, 66
  112. Mukherjee, 1996, Gonadotropins induce rapid phosphorylation of the 3′,5′-cyclic adenosine monophosphate response element binding protein in ovarian granulosa cells, Endocrinology, 137, 3234, 10.1210/endo.137.8.8754745 · doi:10.1210/endo.137.8.8754745
  113. Pei, 1991, Regulation of the α inhibin gene by cyclic adenosine 3′,5′-monophosphate after transfection into rat granulosa cells, Mol Endocrinol, 5, 521, 10.1210/mend-5-4-521 · doi:10.1210/mend-5-4-521
  114. Ardekani, 1998, Structure of the rat inhibin and activin βA-subunit gene and regulation in an ovarian granulosa cell line, Endocrinology, 139, 3271, 10.1210/endo.139.7.6116 · DOI
  115. Matulis, 2012, The LIM domain protein FHL2 interacts with the NR5A family of nuclear receptors and CREB to activate the inhibin-α subunit gene in ovarian granulosa cells, Mol Endocrinol, 26, 1278, 10.1210/me.2011-1347 · DOI
  116. Weck, 2006, Switching of NR5A proteins associated with the inhibin α-subunit gene promoter after activation of the gene in granulosa cells, Mol Endocrinol, 20, 1090, 10.1210/me.2005-0199 · DOI
  117. Woodruff, 1988, Dynamic changes in inhibin messenger RNAs in rat ovarian follicles during the reproductive cycle, Science, 239, 1296, 10.1126/science.3125611 · DOI · Paper page
  118. Camp, 1991, Cellular localization and hormonal regulation of follicle-stimulating hormone and luteinizing hormone receptor messenger RNAs in the rat ovary, Mol Endocrinol, 5, 1405, 10.1210/mend-5-10-1405 · DOI · Paper page
  119. Hickey, 1988, Hormonal regulation, tissue distribution, and content of aromatase cytochrome P450 messenger ribonucleic acid and enzyme in rat ovarian follicles and corpora lutea: relationship to estradiol biosynthesis, Endocrinology, 122, 1426, 10.1210/endo-122-4-1426 · DOI · Paper page
  120. Ronen-Fuhrmann, 1998, Spatio-temporal expression patterns of steroidogenic acute regulatory protein (StAR) during follicular development in the rat ovary, Endocrinology, 139, 303, 10.1210/endo.139.1.5694 · DOI · Paper page
  121. Meldi, 2012, DNA methylation and histone modifications are associated with repression of the inhibin α promoter in the rat corpus luteum, Endocrinology, 153, 4905, 10.1210/en.2012-1292 · DOI
  122. Lenton, 1991, Inhibin concentrations throughout the menstrual cycles of normal, infertile, and older women compared with those during spontaneous conception cycles, J Clin Endocrinol Metab, 73, 1180, 10.1210/jcem-73-6-1180 · DOI
  123. Burkart, 2006, Mechanism of repression of the inhibin α-subunit gene by inducible 3′,5′-cyclic adenosine monophosphate early repressor, Mol Endocrinol, 20, 584, 10.1210/me.2005-0204 · DOI
  124. Burkart, 2005, Repression of the inhibin α-subunit gene by the transcription factor CCAAT/enhancer-binding protein-β, Endocrinology, 146, 1909, 10.1210/en.2004-0842 · DOI
  125. Daopin, 1992, Crystal structure of transforming growth factor-β 2: an unusual fold for the superfamily, Science, 257, 369, 10.1126/science.1631557 · DOI · Paper page
  126. Hart, 2002, Crystal structure of the human TβR2 ectodomain–TGF-β3 complex, Nat Struct Biol, 9, 203
  127. Groppe, 2008, Cooperative assembly of TGF-β superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding, Mol Cell, 29, 157, 10.1016/j.molcel.2007.11.039 · DOI · Paper page
  128. Thompson, 2003, Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-β ligand:receptor interactions, EMBO J, 22, 1555, 10.1093/emboj/cdg156 · DOI · Paper page
  129. Greenwald, 2004, A flexible activin explains the membrane-dependent cooperative assembly of TGF-β family receptors, Mol Cell, 15, 485, 10.1016/j.molcel.2004.07.011 · DOI
  130. Lin, 2006, The structural basis of TGF-β, bone morphogenetic protein, and activin ligand binding, Reproduction, 132, 179, 10.1530/rep.1.01072 · DOI
  131. Kirsch, 2000, Crystal structure of the BMP-2-BRIA ectodomain complex, Nat Struct Biol, 7, 492, 10.1038/75903 · DOI · Paper page
  132. Nickel, 2001, The crystal structure of the BMP-2:BMPR-IA complex and the generation of BMP-2 antagonists, J Bone Joint Surg Am, 83-A, S7
  133. Allendorph, 2007, BMP-3 and BMP-6 structures illuminate the nature of binding specificity with receptors, Biochemistry, 46, 12238, 10.1021/bi700907k · DOI
  134. Saremba, 2008, Type I receptor binding of bone morphogenetic protein 6 is dependent on N-glycosylation of the ligand, FEBS J, 275, 172, 10.1111/j.1742-4658.2007.06187.x · DOI
  135. Greenwald, 2003, The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly, Mol Cell, 11, 605, 10.1016/S1097-2765(03)00094-7 · DOI · Paper page
  136. Brown, 2005, Crystal structure of BMP-9 and functional interactions with pro-region and receptors, J Biol Chem, 280, 25111, 10.1074/jbc.M503328200 · DOI · Paper page
  137. Cash, 2009, The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding, EMBO J, 28, 2662, 10.1038/emboj.2009.205 · DOI · Paper page
  138. Vitt, 2001, Evolution and classification of cystine knot-containing hormones and related extracellular signaling molecules, Mol Endocrinol, 15, 681, 10.1210/mend.15.5.0639 · doi:10.1210/mend.15.5.0639 · Paper page
  139. Mason, 1994, Functional analysis of the cysteine residues of activin A, Mol Endocrinol, 8, 325
  140. Harrington, 2006, Structural basis for the inhibition of activin signalling by follistatin, EMBO J, 25, 1035, 10.1038/sj.emboj.7601000 · DOI · Paper page
  141. Thompson, 2005, The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding, Dev Cell, 9, 535, 10.1016/j.devcel.2005.09.008 · DOI · Paper page
  142. Zhu, 2010, Phylogenomic analyses reveal the evolutionary origin of the inhibin α-subunit, a unique TGFβ superfamily antagonist, PLoS One, 5, e9457, 10.1371/journal.pone.0009457 · DOI
  143. Attisano, 2002, Signal transduction by the TGF-β superfamily, Science, 296, 1646, 10.1126/science.1071809 · DOI · Paper page
  144. Gray, 2000, Identification of a binding site on the type II activin receptor for activin and inhibin, J Biol Chem, 275, 3206, 10.1074/jbc.275.5.3206 · DOI
  145. Greenwald, 1999, Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase, Nat Struct Biol, 6, 18, 10.1038/4887 · DOI
  146. Wuytens, 1999, Identification of two amino acids in activin A that are important for biological activity and binding to the activin type II receptors, J Biol Chem, 274, 9821, 10.1074/jbc.274.14.9821 · DOI
  147. Harrison, 2003, Identification of a functional binding site for activin on the type I receptor ALK4, J Biol Chem, 278, 21129, 10.1074/jbc.M302015200 · DOI
  148. Mathews, 1991, Expression cloning of an activin receptor, a predicted transmembrane serine kinase, Cell, 65, 973, 10.1016/0092-8674(91)90549-E · DOI · Paper page
  149. del Re, 2004, Reconstitution and analysis of soluble inhibin and activin receptor complexes in a cell-free system, J Biol Chem, 279, 53126, 10.1074/jbc.M408090200 · DOI
  150. Kupershmidt, 2007, The neuroprotective effect of activin A and B: implication for neurodegenerative diseases, J Neurochem, 103, 962, 10.1111/j.1471-4159.2007.04785.x · DOI
  151. Tsuchida, 2004, Activin isoforms signal through type I receptor serine/threonine kinase ALK7, Mol Cell Endocrinol, 220, 59, 10.1016/j.mce.2004.03.009 · DOI
  152. Bertolino, 2008, Activin B receptor ALK7 is a negative regulator of pancreatic β-cell function, Proc Natl Acad Sci USA, 105, 7246, 10.1073/pnas.0801285105 · DOI
  153. Ferguson, 1998, Activin is an essential early mesenchymal signal in tooth development that is required for patterning of the murine dentition, Genes Dev, 12, 2636, 10.1101/gad.12.16.2636 · DOI · Paper page
  154. Vassalli, 1994, Activin/inhibin β B subunit gene disruption leads to defects in eyelid development and female reproduction, Genes Dev, 8, 414, 10.1101/gad.8.4.414 · DOI · Paper page
  155. Schrewe, 1994, Mice homozygous for a null mutation of activin β B are viable and fertile, Mech Dev, 47, 43, 10.1016/0925-4773(94)90094-9 · DOI
  156. Matzuk, 1995, Different phenotypes for mice deficient in either activins or activin receptor type II, Nature, 374, 356, 10.1038/374356a0 · DOI · Paper page
  157. Oh, 1997, The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse, Genes Dev, 11, 1812, 10.1101/gad.11.14.1812 · DOI · Paper page
  158. Gu, 1998, The type I activin receptor ActRIB is required for egg cylinder organization and gastrulation in the mouse, Genes Dev, 12, 844, 10.1101/gad.12.6.844 · DOI · Paper page
  159. Jörnvall, 2001, The orphan receptor serine/threonine kinase ALK7 signals arrest of proliferation and morphological differentiation in a neuronal cell line, J Biol Chem, 276, 5140, 10.1074/jbc.M005200200 · DOI
  160. Brown, 2000, Insertion of Inhbb into the Inhba locus rescues the Inhba-null phenotype and reveals new activin functions, Nat Genet, 25, 453, 10.1038/78161 · DOI · Paper page
  161. McNeilly, 2002, Production of inhibin A not B in rams: changes in plasma inhibin A during testis growth, and expression of inhibin/activin subunit mRNA and protein in adult testis, Reproduction, 123, 827, 10.1530/rep.0.1230827 · doi:10.1530/rep.0.1230827
  162. Barakat, 2008, Inhibin, activin, follistatin and FSH serum levels and testicular production are highly modulated during the first spermatogenic wave in mice, Reproduction, 136, 345, 10.1530/REP-08-0140 · doi:10.1530/rep-08-0140
  163. Takehara-Kasamatsu, 2007, Characterization of follistatin-related gene as a negative regulatory factor for activin family members during mouse heart development, J Med Invest, 54, 276, 10.2152/jmi.54.276 · DOI
  164. Wang, 2004, Developmental profiles of activin βA, βB, and follistatin expression in the zebrafish ovary: evidence for their differential roles during sexual maturation and ovulatory cycle, Biol Reprod, 71, 2056, 10.1095/biolreprod.104.032649 · DOI
  165. Phillips, 2001, New developments in the biology of inhibins, activins and follistatins, Trends Endocrinol Metab, 12, 94, 10.1016/S1043-2760(01)00376-9 · DOI
  166. Kocamis, 1999, The ontogeny of myostatin, follistatin and activin-B mRNA expression during chicken embryonic development, Growth Dev Aging, 63, 143
  167. Glister, 2004, Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin, Reproduction, 127, 239, 10.1530/rep.1.00090 · DOI · Paper page
  168. Schneyer, 2008, Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin, Endocrinology, 149, 4589, 10.1210/en.2008-0259 · DOI
  169. Ueno, 1987, Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone, Proc Natl Acad Sci USA, 84, 8282, 10.1073/pnas.84.23.8282 · DOI · Paper page
  170. Robertson, 1987, The isolation of polypeptides with FSH suppressing activity from bovine follicular fluid which are structurally different to inhibin, Biochem Biophys Res Commun, 149, 744, 10.1016/0006-291X(87)90430-X · DOI · Paper page
  171. Lima, 2010, Myostatin and follistatin expression in skeletal muscles of rats with chronic heart failure, Int J Exp Pathol, 91, 54, 10.1111/j.1365-2613.2009.00683.x · DOI
  172. Ogawa, 1993, Expression of α, β A and β B subunits of inhibin or activin and follistatin in rat pancreatic islets, FEBS Lett, 319, 217, 10.1016/0014-5793(93)80549-A · DOI
  173. Petraglia, 1994, Local production and action of follistatin in human placenta, J Clin Endocrinol Metab, 78, 205
  174. Inoue, 1994, Localization of follistatin, an activin-binding protein, in bone tissues, Calcif Tissue Int, 55, 395, 10.1007/BF00299321 · DOI
  175. Michel, 2000, Follistatin (FS) in human cerebrospinal fluid and regulation of FS expression in a mouse model of meningitis, Eur J Endocrinol, 143, 809, 10.1530/eje.0.1430809 · DOI
  176. Sonoyama, 2000, Gene expression of activin, activin receptors, and follistatin in intestinal epithelial cells, Am J Physiol Gastrointest Liver Physiol, 278, G89, 10.1152/ajpgi.2000.278.1.G89 · DOI
  177. Bloise, 2009, Differential expression of follistatin and FLRG in human breast proliferative disorders, BMC Cancer, 9, 320, 10.1186/1471-2407-9-320 · DOI
  178. Shimasaki, 1988, Porcine follistatin gene structure supports two forms of mature follistatin produced by alternative splicing, Biochem Biophys Res Commun, 152, 717, 10.1016/S0006-291X(88)80097-4 · DOI
  179. Sugino, 1993, Molecular heterogeneity of follistatin, an activin-binding protein. Higher affinity of the carboxyl-terminal truncated forms for heparan sulfate proteoglycans on the ovarian granulosa cell, J Biol Chem, 268, 15579, 10.1016/S0021-9258(18)82296-7 · DOI · Paper page
  180. Hashimoto, 1997, A novel role of follistatin, an activin-binding protein, in the inhibition of activin action in rat pituitary cells. Endocytotic degradation of activin and its acceleration by follistatin associated with cell-surface heparan sulfate, J Biol Chem, 272, 13835, 10.1074/jbc.272.21.13835 · DOI · Paper page
  181. Lerch, 2007, Structural and biophysical coupling of heparin and activin binding to follistatin isoform functions, J Biol Chem, 282, 15930, 10.1074/jbc.M700737200 · DOI
  182. Harrison, 2005, Antagonists of activin signaling: mechanisms and potential biological applications, Trends Endocrinol Metab, 16, 73, 10.1016/j.tem.2005.01.003 · DOI · Paper page
  183. Keutmann, 2004, The role of follistatin domains in follistatin biological action, Mol Endocrinol, 18, 228, 10.1210/me.2003-0112 · DOI
  184. Harrison, 2006, Activin-A binds follistatin and type II receptors through overlapping binding sites: generation of mutants with isolated binding activities, Endocrinology, 147, 2744, 10.1210/en.2006-0131 · DOI
  185. Kaiser, 1992, Follistatin gene expression in the pituitary: localization in gonadotropes and folliculostellate cells in diestrous rats, Endocrinology, 130, 3048, 10.1210/endo.130.5.1572312 · DOI
  186. Schneyer, 2003, Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG), Endocrinology, 144, 1671, 10.1210/en.2002-0203 · DOI
  187. Matzuk, 1995, Multiple defects and perinatal death in mice deficient in follistatin, Nature, 374, 360, 10.1038/374360a0 · DOI · Paper page
  188. Lin, 2008, Female infertility and disrupted angiogenesis are actions of specific follistatin isoforms, Mol Endocrinol, 22, 415, 10.1210/me.2006-0529 · DOI
  189. Kimura, 2010, The follistatin-288 isoform alone is sufficient for survival but not for normal fertility in mice, Endocrinology, 151, 1310, 10.1210/en.2009-1176 · DOI
  190. Kimura, 2011, Follistatin regulates germ cell nest breakdown and primordial follicle formation, Endocrinology, 152, 697, 10.1210/en.2010-0950 · DOI
  191. Jorgez, 2004, Granulosa cell-specific inactivation of follistatin causes female fertility defects, Mol Endocrinol, 18, 953, 10.1210/me.2003-0301 · DOI · Paper page
  192. Schneyer, 2001, Follistatin-related protein (FSRP): a new member of the follistatin gene family, Mol Cell Endocrinol, 180, 33, 10.1016/S0303-7207(01)00501-9 · DOI
  193. Tortoriello, 2001, Human follistatin-related protein: a structural homologue of follistatin with nuclear localization, Endocrinology, 142, 3426, 10.1210/endo.142.8.8319 · DOI
  194. Xia, 2004, Overexpression of follistatin-like 3 in gonads causes defects in gonadal development and function in transgenic mice, Mol Endocrinol, 18, 979, 10.1210/me.2003-0364 · DOI
  195. Tsuchida, 2000, Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-β family, J Biol Chem, 275, 40788, 10.1074/jbc.M006114200 · DOI · Paper page
  196. Sidis, 2005, Heparin and activin-binding determinants in follistatin and FSTL3, Endocrinology, 146, 130, 10.1210/en.2004-1041 · DOI
  197. Hill, 2003, Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains, Mol Endocrinol, 17, 1144, 10.1210/me.2002-0366 · DOI · Paper page
  198. Maguer-Satta, 2003, Regulation of human erythropoiesis by activin A, BMP2, and BMP4, members of the TGFβ family, Exp Cell Res, 282, 110, 10.1016/S0014-4827(02)00013-7 · DOI
  199. Otsuka, 2001, Follistatin inhibits the function of the oocyte-derived factor BMP-15, Biochem Biophys Res Commun, 289, 961, 10.1006/bbrc.2001.6103 · DOI
  200. Ciarmela, 2003, Human placenta and fetal membranes express follistatin-related gene mRNA and protein, J Endocrinol Invest, 26, 641, 10.1007/BF03347022 · DOI

200 of 537 shown

Cited by

See all 186

Metadata

Authors
Makanji, Y., Zhu, J., Mishra, R., Holmquist, C., Wong, W. P. S., Schwartz, N. B., Mayo, K. E., & Woodruff, T. K.
Venue
Endocrine Reviews
Published
2014-07-22
Volume
35
Issue
5
Pages
747-794
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
OpenAlex
W2111843622
Cited by
186
References
8
FWCI
9.50
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.